跳至主要内容
临床试验/IRCT2017010431626N2
IRCT2017010431626N2已完成2 期

The effect of added buspiron to atypical antipsychotic drugs in the treatment of negative symptoms in patients with schizophrenia

Vice chancellor for research Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Inclusion Criteria: Age between 18 and 65 years old; Having schizophrenia according to DSM-VI-TR criteria; Bold negative symptoms( PANSS negative symptom sub-scale score more than 15); Disease duration of more than six months
  • Exclusion criteria: Bipolar disorders; Depression and other psychiatric disorders; Chronic medical conditions (liver, kidney and heart); A history of sensitivity to antipsychotics or buspirone; A history of failure to respond to treatment with adequate doses of antipsychotic medication; History of seizures; Pregnancy; Breastfeeding; Any disruption in the electrocardiogram; Simultaneous treatment with other drugs and active suicidal thoughts

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research Ahvaz Jundishapur University of Medical Sciences

相似试验